Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olga Vershinina

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|January 28, 2026
From Data to Decision: Integrating Bioinformatics into Glioma Patient Stratification and Immunotherapy SelectionEkaterina Sleptsova, Olga Vershinina, Mikhail Ivanchenko, et al.
Cancers|August 28, 2025
Explainable Machine Learning Models for Glioma Subtype Classification and Survival PredictionOlga Vershinina, Victoria Turubanova, Mikhail Krivonosov, et al.
Chaos (Woodbury, N.Y.)|December 31, 2020
Quasi-stationary states of game-driven systems: A dynamical approachSergey Denisov, Olga Vershinina, Juzar Thingna, et al.
Cancers|November 27, 2025
Improving the Potential for Predicting Prostate Cancer Progression in Patients on Active Surveillance Using Explainable Artificial IntelligenceOlga Vershinina, Nikita Sushentsev, Alexey Zaikin, et al.
Frontiers in Endocrinology|November 3, 2025
Explainable artificial intelligence model predicting the risk of all-cause mortality in patients with type 2 diabetes mellitusOlga Vershinina, Jacopo Sabbatinelli, Anna Rita Bonfigli, et al.
Frontiers in Immunology|September 20, 2021
Artificial Intelligence Predicts Severity of COVID-19 Based on Correlation of Exaggerated Monocyte Activation, Excessive Organ Damage and Hyperinflammatory Syndrome: A Prospective Clinical StudyOlga Krysko, Elena Kondakova, Olga Vershinina, et al.
Frontiers in Immunology|July 16, 2024
CX3CL1 release during immunogenic apoptosis is associated with enhanced anti-tumour immunityFaye Naessens, Robin Demuynck, Olga Vershinina, et al.
Cell Death & Disease|December 20, 2022
DC vaccines loaded with glioma cells killed by photodynamic therapy induce Th17 anti-tumor immunity and provide a four-gene signature for glioma prognosisMaria Vedunova, Victoria Turubanova, Olga Vershinina, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|January 28, 2026
From Data to Decision: Integrating Bioinformatics into Glioma Patient Stratification and Immunotherapy SelectionEkaterina Sleptsova, Olga Vershinina, Mikhail Ivanchenko, et al.
Cancers|August 28, 2025
Explainable Machine Learning Models for Glioma Subtype Classification and Survival PredictionOlga Vershinina, Victoria Turubanova, Mikhail Krivonosov, et al.
Chaos (Woodbury, N.Y.)|December 31, 2020
Quasi-stationary states of game-driven systems: A dynamical approachSergey Denisov, Olga Vershinina, Juzar Thingna, et al.
Cancers|November 27, 2025
Improving the Potential for Predicting Prostate Cancer Progression in Patients on Active Surveillance Using Explainable Artificial IntelligenceOlga Vershinina, Nikita Sushentsev, Alexey Zaikin, et al.
Frontiers in Endocrinology|November 3, 2025
Explainable artificial intelligence model predicting the risk of all-cause mortality in patients with type 2 diabetes mellitusOlga Vershinina, Jacopo Sabbatinelli, Anna Rita Bonfigli, et al.
Frontiers in Immunology|September 20, 2021
Artificial Intelligence Predicts Severity of COVID-19 Based on Correlation of Exaggerated Monocyte Activation, Excessive Organ Damage and Hyperinflammatory Syndrome: A Prospective Clinical StudyOlga Krysko, Elena Kondakova, Olga Vershinina, et al.
Frontiers in Immunology|July 16, 2024
CX3CL1 release during immunogenic apoptosis is associated with enhanced anti-tumour immunityFaye Naessens, Robin Demuynck, Olga Vershinina, et al.
Cell Death & Disease|December 20, 2022
DC vaccines loaded with glioma cells killed by photodynamic therapy induce Th17 anti-tumor immunity and provide a four-gene signature for glioma prognosisMaria Vedunova, Victoria Turubanova, Olga Vershinina, et al.
Pageof 1